Aporado, Carlo .
HRN: 21-40-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/25/2022
05/31/2022
PO
2 Ml
Q8
İnfectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes